Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 110 entries
View as:

BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study)

Phase: N/A Priority: Normal
NCT ID: NCT04839471 Org: User:
Start: 08/06/21 End: 06/19/24 Due: 06/19/25

Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY)

Phase: N/A Priority: Normal
NCT ID: NCT06981637 Org: User:
Start: 07/01/25 End: 07/31/29 Due: 07/31/30

National Health Interview Survey in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT02843360 Org: User:
Start: 05/31/13 End: 02/28/14 Due: 02/28/15

Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GIST

Phase: N/A Priority: Normal
NCT ID: NCT00359333 Org: User:
Start: 12/31/06 End: 03/31/11 Due: 03/31/12

Blood Pressure and Glucose Lowering Diet for Taiwanese

Phase: N/A Priority: Normal
NCT ID: NCT01364337 Org: User:
Start: 11/30/10 End: 12/31/11 Due: 12/31/12

Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00201383 Org: User:
Start: 10/31/99 End: 08/31/09 Due: 08/31/10

Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT03510871 Org: User:
Start: 02/12/19 End: 05/31/24 Due: 05/31/25

Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET

Phase: N/A Priority: Normal
NCT ID: NCT05385861 Org: User:
Start: 07/18/22 End: 12/31/25 Due: 12/31/26

Implementation and Effectiveness of Multidiscipline-Integrated Addiction Treatment Model

Phase: N/A Priority: Normal
NCT ID: NCT04203654 Org: User:
Start: 02/24/20 End: 12/15/20 Due: 12/15/21

Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)

Phase: N/A Priority: Normal
NCT ID: NCT00201292 Org: User:
Start: 03/31/05 End: 10/31/08 Due: 10/31/09

A Study of High-Risk Oral Cavity Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00934739 Org: User:
Start: 06/30/07 End: 12/31/12 Due: 12/31/13

Observational Registry Data on GIST Patients

Phase: N/A Priority: Normal
NCT ID: NCT03602092 Org: User:
Start: 10/16/18 End: 12/31/25 Due: 12/31/26

Decision Making Deficit and DNA Methylation in Opioid Receptor Genes Among Community Heroin Addicts

Phase: N/A Priority: Normal
NCT ID: NCT01668732 Org: User:
Start: 08/31/12 End: 07/31/15 Due: 07/31/16

A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00149578 Org: User:
Start: 10/31/04 End: 10/31/08 Due: 10/31/09

A Study of Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01063192 Org: User:
Start: 11/30/09 End: 09/30/16 Due: 09/30/17

Pharmacogenomics Study of Sleep Disturbance and Neurocognitive Impairments in the Opioid Addicts

Phase: N/A Priority: Normal
NCT ID: NCT01668706 Org: User:
Start: 03/31/09 End: 12/31/13 Due: 12/31/14

First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT02388581 Org: User:
Start: 12/31/14 End: 12/31/24 Due: 12/31/25

The Molecular Mechanism and the Role of NRAMP 1gene on Tuberculosis in Taiwan Aboriginal Tribes Population

Phase: N/A Priority: Normal
NCT ID: NCT00266383 Org: User:
Start: 01/31/05 End: 12/31/05 Due: 12/31/06

Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05170438 Org: User:
Start: 07/01/22 End: 06/30/28 Due: 06/30/29

Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies

Phase: N/A Priority: Normal
NCT ID: NCT05613621 Org: User:
Start: 11/23/22 End: 12/31/26 Due: 12/31/27

Atezolizumab Plus Bevacizumab With HCC and HBV Infection

Phase: N/A Priority: Normal
NCT ID: NCT04180072 Org: User:
Start: 03/12/20 End: 12/31/25 Due: 12/31/26

A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers

Phase: N/A Priority: Normal
NCT ID: NCT00262210 Org: User:
Start: 06/30/95 End: 12/31/99 Due: 12/31/00

The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05036486 Org: User:
Start: 10/25/21 End: 12/31/30 Due: 12/31/31

An Interventional Study of Geriatric Frailty, Osteoporosis, and Depression

Phase: N/A Priority: Normal
NCT ID: NCT00718432 Org: User:
Start: 04/30/08 End: 12/31/10 Due: 12/31/11

Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00201279 Org: User:
Start: 04/30/99 End: 09/30/12 Due: 09/30/13